Clinical utility of denosumab for treatment of bone loss in men and women
Robert A Adler, Ranjodh S GillEndocrinology and Metabolism, McGuire Veterans Affairs Medical Center, Richmond, VA, USAAbstract: While most older patients with osteoporosis are treated with antiresorptive bisphosphonates such as alendronate, risedronate, ibandronate, and zoledronic acid, such drugs h...
Saved in:
Main Authors: | Adler R, Gill RS |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/75b6a79ef62d4aab9660aac39a7c9067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frequency of osteoporosis in patients with peptic ulcer disease
by: Amber Amin, et al.
Published: (2021) -
Osteonecrosis de los maxilares asociada a medicamentos: revisión de la literatura y propuesta para la prevención y manejo
by: Foncea,Camila, et al.
Published: (2020) -
Osteoporosis in men: epidemiology and treatment with denosumab
by: Sidlauskas KM, et al.
Published: (2014) -
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017) -
Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014)